하시모토 갑상선염과 갑상선유두암
Hashimoto's Thyroiditis and Papillary Thyroid Cancer
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The association of Hashimoto’s thyroiditis (HT) with papillary thyroid cancer (PTC) has been still under debate. Some suggest that these two are positively correlated, whereas other studies report no relationship. We performed a systematic literature review of original studies to investigate the correlation between HT and PTC. The existing data provide inconsistent evidence favoring a causal relationship between HT and PTC. The average prevalence rate of PTC in patients with HT was 1.2% in 8 fine needle aspiration (FNA) studies of 18,023 specimens and 27.6% in 8 archival thyroidectomy studies of 9884 specimens. The risk ratio of PTC in HT specimens ranged from 0.39 to 1.00 in the FNA group (average RR 0.69) in contrast to 1.15 to 4.16 from thyroidectomy studies (average RR 1.59). Population-based fine needle aspiration biopsy studies report no relationship, whereas many of the studies using thyroidectomy specimens report a positive relationship, possibly related to selection bias. Several studies identified a few biomolecular markers, including the PI3K/Akt pathway, RET/PTC gene rearrangements, p63 protein, and loss of heterozygosity of hOGG1, that are potentially involved in neoplastic transformation from HT to PTC. So far, no causal genetic linkage has been confirmed. PTC with concurrent HT is associated with female gender, young age, less aggressive disease such as small tumor size, less frequent capsular invasion and nodal metastasis, and better outcome. However, more prospective studies with long term follow-up are needed to further elucidate this relationship and prognosis. Careful observation and follow-up of HT patients is recommended, especially those with nodular variants.
Abstract
The association of Hashimoto’s thyroiditis (HT) with papillary thyroid cancer (PTC) has been still under debate. Some suggest that these two are positively correlated, whereas other studies report no relationship. We performed a systematic literature review of original studies to investigate the correlation between HT and PTC. The existing data provide inconsistent evidence favoring a causal relationship between HT and PTC. The average prevalence rate of PTC in patients with HT was 1.2% in 8 fine needle aspiration (FNA) studies of 18,023 specimens and 27.6% in 8 archival thyroidectomy studies of 9884 specimens. The risk ratio of PTC in HT specimens ranged from 0.39 to 1.00 in the FNA group (average RR 0.69) in contrast to 1.15 to 4.16 from thyroidectomy studies (average RR 1.59). Population-based fine needle aspiration biopsy studies report no relationship, whereas many of the studies using thyroidectomy specimens report a positive relationship, possibly related to selection bias. Several studies identified a few biomolecular markers, including the PI3K/Akt pathway, RET/PTC gene rearrangements, p63 protein, and loss of heterozygosity of hOGG1, that are potentially involved in neoplastic transformation from HT to PTC. So far, no causal genetic linkage has been confirmed. PTC with concurrent HT is associated with female gender, young age, less aggressive disease such as small tumor size, less frequent capsular invasion and nodal metastasis, and better outcome. However, more prospective studies with long term follow-up are needed to further elucidate this relationship and prognosis. Careful observation and follow-up of HT patients is recommended, especially those with nodular variants.
참고문헌 (36)
- Mazokopakis EE, "Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study", Hormones (Athens), 9(4), pp.312~317 (2010)
- Cipolla C, "Hashimoto thyroiditis coexistent with papillary thyroid carcinoma", Am Surg, (10), pp.874~878 (2005)
- Anderson L, "Hashimoto thyroiditis: Part 2, sonographic analysis of benign and malignant nodules in patients with diffuse Hashimoto thyroiditis", AJR Am J Roentgenol, 195(1), pp.216~222 (2010)
- Davies L, "Increasing incidence of thyroid cancer in the United States, 1973-2002", JAMA, 295(18), pp.2164~2167 (2006)
- Hanafusa T, "Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity", Lancet, 2(8359), pp.1111~1115 (1983)
- Todd I, "Interferon-gamma induces HLA-DR expression by thyroid epithelium", Clin Exp Immunol, 61(2), pp.265~273 (1985)
- Dayan CM, "Chronic autoimmune thyroiditis", N Engl J Med, 335(2), pp.99~107 (1996)
- Salmaso C, "Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves'disease", Ann N Y Acad Sci, 966, pp.496~501 (2002)
- Spencer CA, "Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC)", J Clin Endocrinol Metab, 96(12), pp.3615~3627 (2011)
- Shih ML, "Thyroidectomy for Hashimoto's thyroiditis: complications and associated cancers", Thyroid, 18(7), pp.729~734 (2008)
- Dailey ME, "Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland", AMA Arch Surg, 70(2), pp.291~297 (1955)
- Crile G Jr, "Incidence of cancer in struma lymphomatosa", Surg Gynecol Obstet, 115, pp.101~103 (1962)
- Crile G Jr, "Struma lymphomatosa and carcinoma of the thyroid", Surg Gynecol Obstet, 147(3), pp.350~352 (1978)
- Holm LE, "Cancer risks in patients with chronic lymphocytic thyroiditis", N Engl J Med, 312(10), pp.601~604 (1985)
- Carson HJ, "Incidence of neoplasia in Hashimoto's thyroiditis: a fine-needle aspiration study", Diagn Cytopathol, 14(1), pp.38~42 (1996)
- Erdogan M, "Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto's thyroiditis: results of a university hospital of 769 patients in Turkey", Endocrine, 36(3), pp.486~490 (2009)
- Matesa-Anic D, "Coexistence of papillary carcinoma and Hashimoto's thyroiditis", Acta Clin Croat, 48(1), pp.9~12 (2009)
- Anil C, "Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study", Thyroid, 20(6), pp.601~606 (2010)
- Mukasa K, "Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases", Thyroid, 21(1), pp.37~41 (2011)
- Ott RA, "The incidence of thyroid carcinoma in patients with Hashimoto's thyroiditis and solitary cold nodules", Surgery, 98(6), pp.1202~1206 (1985)
- Repplinger D, "Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer?", J Surg Res, 150(1), pp.49~52 (2008)
- Larson SD, "Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k", Akt pathway, 2007, pp.204(5), 764~773
- Kurukahvecioglu O, "Total thyroidectomy for the treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma", Adv Ther, 24(3), pp.510~516 (2007)
- Bradly DP, "Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases", Surgery, 146(6), pp.1099~1104 (2009)
- Siriweera EH, "Profile of Hashimoto's thyroiditis in Sri Lankans: is there an increased risk of ancillary pathologies in Hashimoto's thyroiditis?", J Thyroid Res, 2010, pp.124264~ (2010)
- Singh B, "Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome", Surgery, 126(6), pp.1070~1076 (1999)
- Tamimi DM, "The association between chronic lymphocytic thyroiditis and thyroid tumors", Int J Surg Pathol, 10(2), pp.141~146 (2002)
- McLeod DS, "Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis", J Clin Endocrinol Metab, 97(8), pp.2682~2692 (2012)
- Mechler C, "Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET", PTC rearrangements, 2001, pp.85(12), 1831~1837
- Unger P, "Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?", Hum Pathol, 34(8), pp.764~ (2003)
- Royer MC, "Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: An analysis of hOGG1 loss of heterozygosity", Arch Otolaryngol Head Neck Surg, 136(3), pp.240~242 (2010)
- Kebebew E, "Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited", World J Surg, 25(5), pp.632~637 (2001)
- Lun Y, "Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis", Otolaryngol Head Neck Surg, 148(3), pp.396~402 (2013)
- Muzza M, "The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies", Clin Endocrinol (Oxf), 72(5), pp.702~708 (2010)
- 정준수, "Coexistence of Chronic Lymphocytic Thyroiditis with Papillary Thyroid Carcinoma: Clinical Manifestation and Prognostic Outcome", Journal of Korean Medical Science, 27(8), pp.883~889 (2012), 대한의학회[DOI]
- Dvorkin S, "Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis", J Clin Endocrinol Metab, 98(6), pp.2409~2414 (2013)